Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional Inhibition of Host Histone Deacetylases (HDACs) Enhances in vitro and in vivo Anti-mycobacterial Activity in Human Macrophages and in Zebrafish
Jôsimar Dornelas Moreira, Bjørn E. V. Koch, Suzanne van Veen, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
Terence C. S. Ho, Alex H. Y. Chan, A. Ganesan
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12460-12484
Open Access | Times Cited: 566
Host‐directed therapy to combat mycobacterial infections*
Gül Kilinç, Anno Saris, Tom H. M. Ottenhoff, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 62-83
Open Access | Times Cited: 100
Host Cell Death and Modulation of Immune Response against Mycobacterium tuberculosis Infection
Annie Vu, Ira Glassman, Giliene Campbell, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6255-6255
Open Access | Times Cited: 10
Host sirtuin 2 as an immunotherapeutic target against tuberculosis
Ashima Bhaskar, Santosh Kumar, Mehak Zahoor Khan, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 59
BCG‐induced protection against Mycobacterium tuberculosis infection: Evidence, mechanisms, and implications for next‐generation vaccines
Mitchell Foster, Philip C. Hill, Todia P. Setiabudiawan, et al.
Immunological Reviews (2021) Vol. 301, Iss. 1, pp. 122-144
Open Access | Times Cited: 43
Mycobacterium tuberculosis: Pathogenesis and therapeutic targets
Jiaxing Yang, Laiying Zhang, Wenliang Qiao, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 20
Host-directed therapy against mycobacterium tuberculosis infections with diabetes mellitus
Li Zhao, Ke Fan, Xue‐Zhi Sun, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 6
Macrophage reprogramming for therapy
Valentina M T Bart, Robert J. Pickering, Philip R. Taylor, et al.
Immunology (2020) Vol. 163, Iss. 2, pp. 128-144
Open Access | Times Cited: 45
Inhibiting Histone Deacetylases in Human Macrophages Promotes Glycolysis, IL-1β, and T Helper Cell Responses to Mycobacterium tuberculosis
Donal J Cox, Amy M. Coleman, Karl M Gogan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 40
Host-acting antibacterial compounds combat cytosolic bacteria
Xiaoye Liu, Yifan Wu, Changsi Mao, et al.
Trends in Microbiology (2022) Vol. 30, Iss. 8, pp. 761-777
Closed Access | Times Cited: 23
Repurposing Tamoxifen as Potential Host-Directed Therapeutic for Tuberculosis
Ralf Boland, Matthias T. Heemskerk, Gabriel Forn‐Cuní, et al.
mBio (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 22
Repurposing HDAC inhibitors to enhance ribonuclease 4 and 7 expression and reduce urinary tract infection
Laura Schwartz, Matthew S. Bochter, Aaron Simoni, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 4
Open Access | Times Cited: 13
Epigenetics in Tuberculosis: Immunomodulation of Host Immune Response
Avinash Khadela, Vivek P. Chavda, Humzah Postwala, et al.
Vaccines (2022) Vol. 10, Iss. 10, pp. 1740-1740
Open Access | Times Cited: 21
Dual GSK-3β/HDAC Inhibitors Enhance the Efficacy of Macrophages to Control Mycobacterium tuberculosis Infection
Sadaf Kalsum, Ruilan Xu, Mira Akber, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 550-550
Open Access
Diving into drug-screening: zebrafish embryos as an in vivo platform for antimicrobial drug discovery and assessment
Eva Habjan, Gina K. Schouten, Alexander Speer, et al.
FEMS Microbiology Reviews (2024) Vol. 48, Iss. 3
Open Access | Times Cited: 3
Identification of kinase inhibitors as potential host-directed therapies for intracellular bacteria
Robin H. G. A. van den Biggelaar, Kimberley V. Walburg, Susan J. F. van den Eeden, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
The miR‐26a/SIRT6/HIF‐1α axis regulates glycolysis and inflammatory responses in host macrophages during Mycobacterium tuberculosis infection
Soumya Mal, Debayan Majumder, Pankaj Birari, et al.
FEBS Letters (2024) Vol. 598, Iss. 20, pp. 2592-2614
Closed Access | Times Cited: 3
Impact of HDAC inhibitors on macrophage polarization to enhance innate immunity against infections
M Bhat, Sonja Srdanović, Lotta‐Riina Sundberg, et al.
Drug Discovery Today (2024), pp. 104193-104193
Open Access | Times Cited: 3
HDAC3 inhibitor RGFP966 controls bacterial growth and modulates macrophage signaling during Mycobacterium tuberculosis infection
Monica Campo, Sarah Heater, Glenna J. Peterson, et al.
Tuberculosis (2021) Vol. 127, pp. 102062-102062
Open Access | Times Cited: 22
Transcription Repressor Protein ZBTB25 Associates with HDAC1-Sin3a Complex in Mycobacterium tuberculosis-Infected Macrophages, and Its Inhibition Clears Pathogen by Autophagy
Aravind Madhavan, K. B. Arun, Akhil Raj Pushparajan, et al.
mSphere (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 18
Sirtuin inhibitors reduce intracellular growth of M. tuberculosis in human macrophages via modulation of host cell immunity
Sadaf Kalsum, Mira Akber, Marco Giulio Loreti, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections
Matthias T. Heemskerk, Cornelis J. Korbee, Jeroen J. Esselink, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 17
Pyruvate Dehydrogenase Kinase Inhibitor Dichloroacetate Improves Host Control of Salmonella enterica Serovar Typhimurium Infection in Human Macrophages
Cassandra L. R. van Doorn, Gina K. Schouten, Suzanne van Veen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Histone deacetylase-2 controls IL-1β production through the regulation of NLRP3 expression and activation in tuberculosis infection
Jôsimar Dornelas Moreira, Alexei Iakhiaev, Ramakrishna Vankayalapati, et al.
iScience (2022) Vol. 25, Iss. 8, pp. 104799-104799
Open Access | Times Cited: 12
Surveying the Epigenetic Landscape of Tuberculosis in Alveolar Macrophages
Katrina Madden, Yi Chu Liang, Nusrah Rajabalee, et al.
Infection and Immunity (2022) Vol. 90, Iss. 5
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top